Role of PCA3 test in clinical decision making for prostate cancer diagnosis

Table 1 Univariable and multivariable association with the adherence with the test recommendations

	Adherent		Univariable		Multivariable
	No (n = 96)	Yes (n = 260)	OR (95%CI)	P value	OR (95%CI)	P value
Age [mean (SD)]	63.3 (6.2)	62.5 (6.8)	0.98 (0.95, 1.02)	0.29		NS
Number of previous biopsies [mean (SD)]	2.04 (1.12)	2.01 (1.08)	0.97 (0.79, 1.20)	0.794		NS
Biopsy last result-HGPIN/ASAP	24 (25.0%)	64 (24.7%)	0.99 (0.57, 1.69)	0.955		NS
Family history	4 (4.2%)	38 (14.7%)	3.96 (1.37, 11.40)	0.011	3.80 (1.31, 11.05)	0.014
Last PSA ≥ 10	41 (42.7%)	59 (22.8%)	0.40 (0.24, 0.65)	< 0.001	0.40 (0.24, 0.67)	< 0.001

HGPIN: High grade prostate intraepithelial neoplasia; ASAP: Atypical small acinar proliferation; PSA: Prostate specific antigen; OR: Odds ratio; NS: Not significant; SD: Standard deviation.